Skip to Main Content

Author Details

Masaki Terabe
National Cancer Institute
1997
90
40
PMIDPaper TitleJournal TitlePublished Year
36418073Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.J Immunother Cancer2022
33367885Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.Neuro Oncol2021
33520712Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.Front Oncol2021
34976830Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.Front Oncol2021
34524664Detection of Mouse Type I NKT (iNKT) Cells by Flow Cytometry.Methods Mol Biol2021
34041034Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma.Front Oncol2021
34244788Rethinking immunotherapy in meningiomas.Neuro Oncol2021
34208864The Role of NKT Cells in Glioblastoma.Cells2021
32219267Synthetic preparation and immunological evaluation of β-mannosylceramide and related N-acyl analogues.Org Biomol Chem2020
33709018Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA).Adv Ther (Weinh)2020
31909413Another layer of immune complication in glioblastoma: inducible co-stimulator and its ligand.Neuro Oncol2020
31948558Complementary approaches to study NKT cells in cancer.Methods Enzymol2020
32642716MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment.Neurooncol Adv2020
31620124Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.Front Immunol2019
31646070Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory.Oncoimmunology2019
31649670Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.Front Immunol2019
31258878High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.J Extracell Vesicles2019
29143114Cancer vaccine strategies: translation from mice to human clinical trials.Cancer Immunol Immunother2018
30158927Tissue-Specific Roles of NKT Cells in Tumor Immunity.Front Immunol2018
29900040Differential Regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin.Oncoimmunology2018
29554495Cancer vaccines: translation from mice to human clinical trials.Curr Opin Immunol2018
29520281Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.Front Immunol2018
29798856Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.Science2018
29677387IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF<sup>+</sup> innate T cells in the human liver.Eur J Immunol2018
28073842Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients.Clin Cancer Res2017
28500324Labeling Extracellular Vesicles for Nanoscale Flow Cytometry.Sci Rep2017
29079845Glycolipid-peptide conjugate vaccines enhance CD8<sup>+</sup> T cell responses against human viral proteins.Sci Rep2017
28674083Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity.Cancer Immunol Res2017
28638730Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.Oncoimmunology2017
26934227NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Nature2016
27622067TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.Oncoimmunology2016
25616156Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.Eur J Immunol2015
24384834The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.Cancer Immunol Immunother2014
25297630CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.Cancer Res2014
25389427NKT cell networks in the regulation of tumor immunity.Front Immunol2014
23319803Delicate balance among three types of T cells in concurrent regulation of tumor immunity.Cancer Res2013
24124874Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.Expert Rev Vaccines2013
23750208Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.PLoS One2013
23804426β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy.Clin Cancer Res2013
23762801Balance is a key for happiness.Oncoimmunology2013
22595057Strategies to use immune modulators in therapeutic vaccines against cancer.Semin Oncol2012
21245578Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.J Clin Invest2011
22013118A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models.J Immunol2011
21482696KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells.J Exp Med2011
21474552IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses.J Leukoc Biol2011
19830696Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.Int J Cancer2010
20457926Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.Proc Natl Acad Sci U S A2010
19710907Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.PLoS One2009
19861451Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.Clin Cancer Res2009
19689293The contrasting roles of NKT cells in tumor immunity.Curr Mol Med2009
  • 1 - 50 of 90

Recommended Authors

Dipti Vijayan
QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Moutih Rafei
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 3
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Glenda Canderan
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 0
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 6
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 0
Ursula Grohmann
University of Perugia
Career Start Year 1988
Number of shared co-authors 1
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 2
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 5
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 3
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 12
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 6
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 7
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 12

Collaborators

Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 74
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 5
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Raj K Puri
Co-authored papers 3
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Jennifer C Jones
Co-authored papers 3
Amiran Dzutsev
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Miaojun Han
Department of Research and Development, Shanghai United Imaging Intelligence Co.
Co-authored papers 2
William G Telford
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 2
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Faith C Robertson
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 2
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers 1
Wuxing Yuan
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Qiong Fu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Joshua A Welsh
Co-authored papers 1
Bernd Heinrich
Clinic for Gastroenterology, Hannover Medical School
Co-authored papers 1
Chand Khanna
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Shurjo K Sen
Louisiana State University
Co-authored papers 1
Mathuros Ruchirawat
Chulabhorn Research Institute
Co-authored papers 1
Tianxia Wu
Co-authored papers 1
John A McCulloch
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Daniel W McVicar
National Cancer Institute
Co-authored papers 1
Casey M Theriot
College of Veterinary Medicine, North Carolina State University
Co-authored papers 1
Markku Miettinen
National Cancer Institute
Co-authored papers 1
Kenneth Aldape
National Cancer Institute
Co-authored papers 1
Joseph F Costello
University of California san francisco
Co-authored papers 1
Milan Sandhu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Ligia A Pinto
Frederick National Laboratory for Cancer Research
Co-authored papers 1
Release 1.2